Article

New eye vitamin introduced by Bausch & Lomb for diabetes

Boston-Bausch & Lomb has introduced a new eye vitamin supplement, Ocuvite DF, for patients with diabetes.

Boston-Bausch & Lomb has introduced a new eye vitamin supplement, Ocuvite DF, for patients with diabetes.

The vitamin contains an antioxidant called genistein, which battles free radicals and reduces oxidative stress. Nutritional supplements are also required to maintain general eye health because of "shortfalls in Americans' nutritional intake," said Anthony Cavallerano, OD, FAAO, an optometrist at the VA Boston Health Care System and professor of optometry at the New England College of Optometry.

Other product offerings from the company include Ocuvite Adult and Ocuvite Adult 50+ eye vitamin and mineral supplement formulations.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.